Literature DB >> 30193121

Influence of different lignan compounds on enterolignan production by Bifidobacterium and Lactobacillus strains.

Ángela Peirotén1, Pilar Gaya1, Inmaculada Álvarez2, Daniel Bravo1, José Mª Landete3.   

Abstract

Enterolignans, i.e. enterodiol and enterolactone, are polyphenols derived from the microbial metabolism of dietary lignans. They are considered phytoestrogens because of their estrogenic/antiestrogenic activity, which confers them benefits to human health when they reach sufficient levels in plasma. Hence, there is a great interest in studying the bacteria involved in enterolignan production. In the present study, three bifidobacterial strains (Bifidobacterium bifidum INIA P466, Bifidobacterium catenulatum INIA P732 and Bifidobacterium pseudolongum INIA P2) were found capable of producing low levels of enterodiol (2-11 μM) from lignan extracts; while another one (Bifidobacterium pseudocatenulatum INIA P946) was found to produce an important increment of the lignan secoisolariciresinol (SECO). Subsequently, the three enterodiol-producing bifidobacteria and another three Lactobacillus strains previously identified as enterolignans producers (Lactobacillus gasseri INIA P508, Lactobacillus salivarius INIA P448 and Lb. salivarius INIA P183), were tested on pure lignans yielding both enterodiol and enterolactone from secoisolariciresinol (SECO), while they did not metabolised the other lignan tested (i.e. matairesinol). B. catenulatum INIA P732 and Lb. gasseri INIA P508 were the strains that transformed the greatest percentage of SECO, yielding enterolactone concentrations above 2 mM. In addition, the formation of the intermediate compound dihydroxyenterodiol was observed as part of SECO transformation by all the strains. In this work, we have demonstrated for the first time how strains of Bifidobacterium and Lactobacillus are capable of carrying out the complete enterolignan metabolism, transforming a purified lignan (SECO) into enterodiol and enterolactone. The isolation and characterization of bacteria able to metabolize lignans and produce enterolignans, especially belonging to Bifidobacterium and Lactobacillus genera, is of biotechnological interest, because of their potential application in functional foods and as probiotics.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bifidobacteria; Enterodiol; Enterolactone; Food; Lactobacilli; Lignans

Mesh:

Substances:

Year:  2018        PMID: 30193121     DOI: 10.1016/j.ijfoodmicro.2018.08.028

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  6 in total

1.  The Comparative Analysis of Genomic Diversity and Genes Involved in Carbohydrate Metabolism of Eighty-Eight Bifidobacterium pseudocatenulatum Isolates from Different Niches of China.

Authors:  Guopeng Lin; Qian Liu; Luyao Wang; Haitao Li; Jianxin Zhao; Hao Zhang; Gang Wang; Wei Chen
Journal:  Nutrients       Date:  2022-06-04       Impact factor: 6.706

Review 2.  Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way.

Authors:  Ludovico Abenavoli; Luigi Boccuto; Alessandro Federico; Marcello Dallio; Carmelina Loguercio; Laura Di Renzo; Antonino De Lorenzo
Journal:  Int J Environ Res Public Health       Date:  2019-08-21       Impact factor: 3.390

3.  The Diversity of the CRISPR-Cas System and Prophages Present in the Genome Reveals the Co-evolution of Bifidobacterium pseudocatenulatum and Phages.

Authors:  Gang Wang; Qian Liu; Zhangming Pei; Linlin Wang; Peijun Tian; Zhenmin Liu; Jianxin Zhao; Hao Zhang; Wei Chen
Journal:  Front Microbiol       Date:  2020-05-26       Impact factor: 5.640

Review 4.  Lignans and Gut Microbiota: An Interplay Revealing Potential Health Implications.

Authors:  Alice Senizza; Gabriele Rocchetti; Juana I Mosele; Vania Patrone; Maria Luisa Callegari; Lorenzo Morelli; Luigi Lucini
Journal:  Molecules       Date:  2020-12-03       Impact factor: 4.411

5.  Enterolignan Production in a Flaxseed Intervention Study in Postmenopausal US Women of African Ancestry and European Ancestry.

Authors:  Susan E McCann; Meredith A J Hullar; David L Tritchler; Eduardo Cortes-Gomez; Song Yao; Warren Davis; Tracey O'Connor; Deborah Erwin; Lilian U Thompson; Li Yan; Johanna W Lampe
Journal:  Nutrients       Date:  2021-03-12       Impact factor: 5.717

Review 6.  Potential Modulatory Microbiome Therapies for Prevention or Treatment of Inflammatory Bowel Diseases.

Authors:  Daan V Bunt; Adriaan J Minnaard; Sahar El Aidy
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.